KYMR logo

Kymera Therapeutics (KYMR) Working capital

annual working capital:

$442.50M+$122.88M(+38.44%)
December 31, 2024

Summary

  • As of today (July 1, 2025), KYMR annual working capital is $442.50 million, with the most recent change of +$122.88 million (+38.44%) on December 31, 2024.
  • During the last 3 years, KYMR annual working capital has risen by +$83.77 million (+23.35%).
  • KYMR annual working capital is now at all-time high.

Performance

KYMR Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

quarterly working capital:

$441.96M-$539.00K(-0.12%)
March 31, 2025

Summary

  • As of today (July 1, 2025), KYMR quarterly working capital is $441.96 million, with the most recent change of -$539.00 thousand (-0.12%) on March 31, 2025.
  • Over the past year, KYMR quarterly working capital has dropped by -$39.16 million (-8.14%).
  • KYMR quarterly working capital is now -11.99% below its all-time high of $502.18 million, reached on September 30, 2024.

Performance

KYMR quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

KYMR Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+38.4%-8.1%
3 y3 years+23.4%+28.8%
5 y5 years+659.3%-

KYMR Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+38.4%-12.0%+41.4%
5 y5-yearat high+659.3%-12.0%+282.3%
alltimeall timeat high+1092.6%-12.0%+658.4%

KYMR Working capital History

DateAnnualQuarterly
Mar 2025
-
$441.96M(-0.1%)
Dec 2024
$442.50M(+38.4%)
$442.50M(-11.9%)
Sep 2024
-
$502.18M(+8.4%)
Jun 2024
-
$463.26M(-3.7%)
Mar 2024
-
$481.12M(+50.5%)
Dec 2023
$319.63M(-8.2%)
$319.63M(+2.3%)
Sep 2023
-
$312.53M(-5.5%)
Jun 2023
-
$330.80M(-5.4%)
Mar 2023
-
$349.62M(+0.4%)
Dec 2022
$348.07M
$348.07M(-13.6%)
Sep 2022
-
$402.90M(+27.8%)
DateAnnualQuarterly
Jun 2022
-
$315.27M(-8.1%)
Mar 2022
-
$343.04M(-4.4%)
Dec 2021
$358.73M(+87.1%)
$358.73M(-20.1%)
Sep 2021
-
$449.24M(+75.4%)
Jun 2021
-
$256.12M(+11.0%)
Mar 2021
-
$230.65M(+20.3%)
Dec 2020
$191.72M(+229.0%)
$191.72M(+0.9%)
Sep 2020
-
$190.08M(+64.4%)
Jun 2020
-
$115.62M(+98.4%)
Dec 2019
$58.27M(+57.1%)
$58.27M
Dec 2018
$37.10M
-

FAQ

  • What is Kymera Therapeutics annual working capital?
  • What is the all time high annual working capital for Kymera Therapeutics?
  • What is Kymera Therapeutics annual working capital year-on-year change?
  • What is Kymera Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Kymera Therapeutics?
  • What is Kymera Therapeutics quarterly working capital year-on-year change?

What is Kymera Therapeutics annual working capital?

The current annual working capital of KYMR is $442.50M

What is the all time high annual working capital for Kymera Therapeutics?

Kymera Therapeutics all-time high annual working capital is $442.50M

What is Kymera Therapeutics annual working capital year-on-year change?

Over the past year, KYMR annual working capital has changed by +$122.88M (+38.44%)

What is Kymera Therapeutics quarterly working capital?

The current quarterly working capital of KYMR is $441.96M

What is the all time high quarterly working capital for Kymera Therapeutics?

Kymera Therapeutics all-time high quarterly working capital is $502.18M

What is Kymera Therapeutics quarterly working capital year-on-year change?

Over the past year, KYMR quarterly working capital has changed by -$39.16M (-8.14%)
On this page